Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features

Accumulating evidence indicates that specific strains of mucosa-associated Escherichia coli (E. coli) can influence the development of colorectal carcinoma. This study aimed to investigate the prevalence and characterization of mucosa-associated E. coli obtained from the colorectal cancer (CRC) pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Roghayeh Nouri, Alka Hasani, Kourosh Masnadi Shirazi, Mohammad Reza Alivand, Bita Sepehri, Simin Sotoudeh, Fatemeh Hemmati, Afshin Fattahzadeh, Babak Abdinia, Mohammad Ahangarzadeh Rezaee
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2021/2131787
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560968040710144
author Roghayeh Nouri
Alka Hasani
Kourosh Masnadi Shirazi
Mohammad Reza Alivand
Bita Sepehri
Simin Sotoudeh
Fatemeh Hemmati
Afshin Fattahzadeh
Babak Abdinia
Mohammad Ahangarzadeh Rezaee
author_facet Roghayeh Nouri
Alka Hasani
Kourosh Masnadi Shirazi
Mohammad Reza Alivand
Bita Sepehri
Simin Sotoudeh
Fatemeh Hemmati
Afshin Fattahzadeh
Babak Abdinia
Mohammad Ahangarzadeh Rezaee
author_sort Roghayeh Nouri
collection DOAJ
description Accumulating evidence indicates that specific strains of mucosa-associated Escherichia coli (E. coli) can influence the development of colorectal carcinoma. This study aimed to investigate the prevalence and characterization of mucosa-associated E. coli obtained from the colorectal cancer (CRC) patients and control group. At two referral university-affiliated hospitals in northwest Iran, 100 patients, 50 with CRC and 50 without, were studied over the course of a year. Fresh biopsy specimens were used to identify mucosa-associated E. coli isolates after dithiothreitol mucolysis. To classify the E. coli strains, ten colonies per sample were typed using enterobacterial repetitive intergenic consensus-based PCR (ERIC-PCR). The strains were classified into phylogroups using the quadruplex PCR method. The PCR method was used to examine for the presence of cyclomodulin, bfp, stx1, stx2, and eae-encoding genes. The strains were tested for biofilm formation using the microtiter plate assay. CRC patients had more mucosa-associated E. coli than the control group (p<0.05). Enteropathogenic Escherichia coli (EPEC) was also found in 23% of CRC strains and 7.1% of control strains (p<0.05). Phylogroup A was predominant in control group specimens, while E. coli isolates from CRC patients belonged most frequently to phylogroups D and B2. Furthermore, the frequency of cyclomodulin-encoding genes in the CRC patients was significantly higher than the control group. Around 36.9% of E. coli strains from CRC samples were able to form biofilms, compared to 16.6% E. coli strains from the control group (p<0.05). Noticeably, cyclomodulin-positive strains were more likely to form biofilm in comparison to cyclomodulin-negative strains (p<0.05). In conclusion, mucosa-associated E. coli especially cyclomodulin-positive isolates from B2 and D phylogroups possessing biofilm-producing capacity colonize the gut mucosa of CRC patients.
format Article
id doaj-art-c272939ecd014d0b93835723f23d007b
institution Kabale University
issn 1918-1493
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-c272939ecd014d0b93835723f23d007b2025-02-03T01:26:24ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932021-01-01202110.1155/2021/2131787Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing FeaturesRoghayeh Nouri0Alka Hasani1Kourosh Masnadi Shirazi2Mohammad Reza Alivand3Bita Sepehri4Simin Sotoudeh5Fatemeh Hemmati6Afshin Fattahzadeh7Babak Abdinia8Mohammad Ahangarzadeh Rezaee9Student Research CommitteeInfectious and Tropical Diseases Research CenterLiver and Gastrointestinal Diseases Research CenterDepartment of Medical GeneticsLiver and Gastrointestinal Diseases Research CenterLiver and Gastrointestinal Diseases Research CenterStudent Research CommitteeLiver and Gastrointestinal Diseases Research CenterPediatric Health Research CenterInfectious and Tropical Diseases Research CenterAccumulating evidence indicates that specific strains of mucosa-associated Escherichia coli (E. coli) can influence the development of colorectal carcinoma. This study aimed to investigate the prevalence and characterization of mucosa-associated E. coli obtained from the colorectal cancer (CRC) patients and control group. At two referral university-affiliated hospitals in northwest Iran, 100 patients, 50 with CRC and 50 without, were studied over the course of a year. Fresh biopsy specimens were used to identify mucosa-associated E. coli isolates after dithiothreitol mucolysis. To classify the E. coli strains, ten colonies per sample were typed using enterobacterial repetitive intergenic consensus-based PCR (ERIC-PCR). The strains were classified into phylogroups using the quadruplex PCR method. The PCR method was used to examine for the presence of cyclomodulin, bfp, stx1, stx2, and eae-encoding genes. The strains were tested for biofilm formation using the microtiter plate assay. CRC patients had more mucosa-associated E. coli than the control group (p<0.05). Enteropathogenic Escherichia coli (EPEC) was also found in 23% of CRC strains and 7.1% of control strains (p<0.05). Phylogroup A was predominant in control group specimens, while E. coli isolates from CRC patients belonged most frequently to phylogroups D and B2. Furthermore, the frequency of cyclomodulin-encoding genes in the CRC patients was significantly higher than the control group. Around 36.9% of E. coli strains from CRC samples were able to form biofilms, compared to 16.6% E. coli strains from the control group (p<0.05). Noticeably, cyclomodulin-positive strains were more likely to form biofilm in comparison to cyclomodulin-negative strains (p<0.05). In conclusion, mucosa-associated E. coli especially cyclomodulin-positive isolates from B2 and D phylogroups possessing biofilm-producing capacity colonize the gut mucosa of CRC patients.http://dx.doi.org/10.1155/2021/2131787
spellingShingle Roghayeh Nouri
Alka Hasani
Kourosh Masnadi Shirazi
Mohammad Reza Alivand
Bita Sepehri
Simin Sotoudeh
Fatemeh Hemmati
Afshin Fattahzadeh
Babak Abdinia
Mohammad Ahangarzadeh Rezaee
Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
Canadian Journal of Infectious Diseases and Medical Microbiology
title Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
title_full Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
title_fullStr Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
title_full_unstemmed Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
title_short Mucosa-Associated Escherichia coli in Colorectal Cancer Patients and Control Subjects: Variations in the Prevalence and Attributing Features
title_sort mucosa associated escherichia coli in colorectal cancer patients and control subjects variations in the prevalence and attributing features
url http://dx.doi.org/10.1155/2021/2131787
work_keys_str_mv AT roghayehnouri mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT alkahasani mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT kouroshmasnadishirazi mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT mohammadrezaalivand mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT bitasepehri mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT siminsotoudeh mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT fatemehhemmati mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT afshinfattahzadeh mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT babakabdinia mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures
AT mohammadahangarzadehrezaee mucosaassociatedescherichiacoliincolorectalcancerpatientsandcontrolsubjectsvariationsintheprevalenceandattributingfeatures